{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:23:04Z","timestamp":1791573784475,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1084416"],"award-info":[{"award-number":["1084416"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1008349"],"award-info":[{"award-number":["1008349"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["646876"],"award-info":[{"award-number":["646876"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-13-2-0093"],"award-info":[{"award-number":["W81XWH-13-2-0093"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007568","name":"Urology Foundation","doi-asserted-by":"publisher","award":["RESCH1302"],"award-info":[{"award-number":["RESCH1302"]}],"id":[{"id":"10.13039\/501100007568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L00156X\/1"],"award-info":[{"award-number":["MR\/L00156X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["PS-15-041"],"award-info":[{"award-number":["PS-15-041"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.mce.2016.11.016","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:15:08Z","timestamp":1479914108000},"page":"138-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity"],"prefix":"10.1016","volume":"440","author":[{"given":"Adam W.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud J.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Y.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard A.","family":"Tarulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne D.","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita S.","family":"Katzenellenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Hawse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent J.","family":"Gnanapragasam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-0080","authenticated-orcid":false,"given":"Jason S.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2016.11.016_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgt156","article-title":"High circulating estrogens and selective expression of ERbeta in prostate tumors: implications for racial disparity of prostate Cancer","author":"Abd Elmageed","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2016.11.016_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3892\/etm.2011.226","article-title":"Analysis of estrogen receptor isoforms and variants in breast cancer cell lines","volume":"2","author":"Al-Bader","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.mce.2016.11.016_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/10408444.2010.541900","article-title":"Risks and benefits of dietary isoflavones for cancer","volume":"41","author":"Andres","year":"2011","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.mce.2016.11.016_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1746-1596-6-61","article-title":"Estrogen receptor beta expression in prostate adenocarcinoma","volume":"6","author":"Asgari","year":"2011","journal-title":"Diagn Pathol."},{"key":"10.1016\/j.mce.2016.11.016_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pros.21507","article-title":"Opposing roles of ERalpha and ERbeta in the genesis and progression of adenocarcinoma in the rat ventral prostate","volume":"72","author":"Attia","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2016.11.016_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/521274a","article-title":"Reproducibility crisis: blame it on the antibodies","volume":"521","author":"Baker","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mce.2016.11.016_bib7","first-page":"2366","article-title":"A\u00a0Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer","volume":"5","author":"Bergan","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2144\/000113382","article-title":"Antibody validation","volume":"48","author":"Bordeaux","year":"2010","journal-title":"Biotechniques"},{"key":"10.1016\/j.mce.2016.11.016_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsbmb.2013.03.003","article-title":"Estrogen receptor beta: tissue distribution and the still largely enigmatic physiological function","volume":"139","author":"Bottner","year":"2014","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2016.11.016_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pros.21257","article-title":"Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer","volume":"71","author":"Bouchal","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2016.11.016_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10549-004-4262-8","article-title":"A\u00a0multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue","volume":"92","author":"Carder","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2016.11.016_bib12","first-page":"2172","article-title":"Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression","volume":"184","author":"Celhay","year":"2010","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.mce.2016.11.016_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<115::AID-PROS7>3.0.CO;2-3","article-title":"Estrogen receptor-beta: implications for the prostate gland","volume":"40","author":"Chang","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2016.11.016_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/carcin\/bgn288","article-title":"CCDC62\/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells","volume":"30","author":"Chen","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2016.11.016_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0303-7207(01)00492-0","article-title":"Human estrogen receptor beta-specific monoclonal antibodies: characterization and use in studies of estrogen receptor beta protein expression in reproductive tissues","volume":"181","author":"Choi","year":"2001","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2013.12.027","article-title":"Prognostic significance of the estrogen receptor beta (ERbeta) isoforms ERbeta1, ERbeta2, and ERbeta5 in advanced serous ovarian cancer","volume":"132","author":"Ciucci","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mce.2016.11.016_bib17","doi-asserted-by":"crossref","first-page":"801473","DOI":"10.1155\/2014\/801473","article-title":"Vitro chronic administration of ERbeta selective ligands and prostate Cancer cell growth: hypotheses on the selective role of 3beta-Adiol in AR-positive RV1 cells","volume":"2014","author":"Colciago","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.mce.2016.11.016_bib18","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/onc.2012.261","article-title":"Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells","volume":"32","author":"Cotrim","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2016.11.016_bib19","doi-asserted-by":"crossref","first-page":"T61","DOI":"10.1530\/JME-13-0150","article-title":"Insight into the mechanisms of action of estrogen receptor beta in the breast, prostate, colon, and CNS","volume":"51","author":"Dey","year":"2013","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/me.2012.1227","article-title":"Estrogen receptors beta1 and beta2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate Cancer cell line PC3","author":"Dey","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib21","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1038\/onc.2013.384","article-title":"Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer","volume":"33","author":"Dey","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2016.11.016_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrc2174","article-title":"Treating prostate cancer: a rationale for targeting local oestrogens","volume":"7","author":"Ellem","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.4386","article-title":"A\u00a0pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment","volume":"234","author":"Ellem","year":"2014","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.mce.2016.11.016_bib24","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1158\/1078-0432.CCR-04-0389","article-title":"Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer","volume":"10","author":"Esslimani-Sahla","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib25","doi-asserted-by":"crossref","first-page":"e1000108","DOI":"10.1371\/journal.pgen.1000108","article-title":"Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma","volume":"4","author":"Foryst-Ludwig","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mce.2016.11.016_bib26","first-page":"5425","article-title":"Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer","volume":"59","author":"Fuqua","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib27","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1074\/mcp.O112.019802","article-title":"Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer","volume":"11","author":"Gallien","year":"2012","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mce.2016.11.016_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/molehr\/8.8.770","article-title":"Estrogen receptor-alpha and -beta expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma","volume":"8","author":"Gargett","year":"2002","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.mce.2016.11.016_bib29","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/me.2011-1371","article-title":"A\u00a0local paracrine and endocrine network involving TGFbeta, Cox-2, ROS, and estrogen receptor beta influences reactive stromal cell regulation of prostate cancer cell motility","volume":"26","author":"Grubisha","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib30","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1158\/1078-0432.CCR-06-1823","article-title":"Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma","volume":"13","author":"Gruvberger-Saal","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3892\/etm.2014.1634","article-title":"Correlation between estrogen receptor beta expression and the curative effect of endocrine therapy in breast cancer patients","volume":"7","author":"Guo","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.mce.2016.11.016_bib32","first-page":"3730","article-title":"Expression and prognostic value of estrogen receptor beta in breast cancer patients","volume":"7","author":"Guo","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.mce.2016.11.016_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.mce.2013.08.005","article-title":"Estrogen receptor beta in breast cancer","volume":"382","author":"Haldosen","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2015.10.034","article-title":"Estrogen receptor beta modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis","volume":"163","author":"Han","year":"2015","journal-title":"Cell."},{"key":"10.1016\/j.mce.2016.11.016_bib35","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.steroids.2012.07.002","article-title":"Current concepts and significance of estrogen receptor beta in prostate cancer","volume":"77","author":"Hartman","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2016.11.016_bib36","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3892\/ol.2015.3081","article-title":"Clinical features and prognosis-associated factors of non-small cell lung cancer exhibiting symptoms of bone metastasis at the time of diagnosis","volume":"9","author":"He","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.mce.2016.11.016_bib37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1940-6207.CAPR-15-0198","article-title":"ERbeta expression and breast Cancer risk prediction for women with atypias","volume":"8","author":"Hieken","year":"2015","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.mce.2016.11.016_bib38","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3892\/ijo.2014.2778","article-title":"Estrogen receptor beta selective agonists reduce invasiveness of triple-negative breast cancer cells","volume":"46","author":"Hinsche","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mce.2016.11.016_bib39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/me.2010-0040","article-title":"Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions","volume":"24","author":"Holbeck","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib40","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1464-410X.2010.09897.x","article-title":"Prostate cancer and diet: food for thought?","volume":"107","author":"Hori","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.mce.2016.11.016_bib41","first-page":"5331","article-title":"Frequent loss of estrogen receptor-beta expression in prostate cancer","volume":"61","author":"Horvath","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrurol.2013.53","article-title":"Role of oestrogen receptors in bladder cancer development","volume":"10","author":"Hsu","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.mce.2016.11.016_bib43","doi-asserted-by":"crossref","first-page":"e40732","DOI":"10.1371\/journal.pone.0040732","article-title":"Estrogen receptor beta activation impairs prostatic regeneration by inducing apoptosis in murine and human stem\/progenitor enriched cell populations","volume":"7","author":"Hussain","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2016.11.016_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/ERC-13-0444","article-title":"Support of a bi-faceted role of estrogen receptor beta (ERbeta) in ERalpha-positive breast cancer cells","volume":"21","author":"Jonsson","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib45","first-page":"5365","article-title":"Raloxifene, a mixed estrogen agonist\/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib46","first-page":"3649","article-title":"Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"Koressaar","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.mce.2016.11.016_bib48","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","article-title":"Cloning of a novel receptor expressed in rat prostate and ovary","volume":"93","author":"Kuiper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.11.016_bib49","first-page":"3175","article-title":"Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation","volume":"60","author":"Lau","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0002-9440(10)61676-8","article-title":"Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma","volume":"159","author":"Leav","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mce.2016.11.016_bib51","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1677\/ERC-09-0294","article-title":"Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion","volume":"17","author":"Leung","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib52","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1073\/pnas.0605676103","article-title":"Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling","volume":"103","author":"Leung","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.11.016_bib53","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/ERC-12-0389","article-title":"A\u00a0bi-faceted role of estrogen receptor beta in breast cancer","volume":"20","author":"Leygue","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.mce.2016.11.016_bib55","first-page":"8686","article-title":"Overexpression of estrogen receptor beta is a prognostic marker in non-small cell lung cancer: a meta-analysis","volume":"8","author":"Luo","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.mce.2016.11.016_bib56","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/msb.2013.28","article-title":"Integrative genomics of gene and metabolic regulation by estrogen receptors alpha and beta, and their coregulators","volume":"9","author":"Madak-Erdogan","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mce.2016.11.016_bib57","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1073\/pnas.1221654110","article-title":"Estrogen receptor beta sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription","volume":"110","author":"Mak","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.11.016_bib58","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.celrep.2015.02.063","article-title":"Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor beta repression","volume":"10","author":"Mak","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.mce.2016.11.016_bib59","doi-asserted-by":"crossref","first-page":"40247","DOI":"10.18632\/oncotarget.5377","article-title":"ERbeta regulation of NF-kB activation in prostate cancer is mediated by HIF-1","volume":"6","author":"Mak","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mce.2016.11.016_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35043102","article-title":"Human cancer cell lines: fact and fantasy","volume":"1","author":"Masters","year":"2000","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.mce.2016.11.016_bib61","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/en.2006-0906","article-title":"Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia","volume":"148","author":"McPherson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2016.11.016_bib62","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1073\/pnas.0905524107","article-title":"Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated","volume":"107","author":"McPherson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.11.016_bib63","doi-asserted-by":"crossref","first-page":"2289S","DOI":"10.3945\/jn.110.124107","article-title":"Insights gained from 20 years of soy research","volume":"140","author":"Messina","year":"2010","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.mce.2016.11.016_bib64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.celrep.2013.01.010","article-title":"Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor","volume":"3","author":"Mohammed","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.mce.2016.11.016_bib65","doi-asserted-by":"crossref","first-page":"e0131901","DOI":"10.1371\/journal.pone.0131901","article-title":"Changes in estrogen receptor ERbeta (ESR2) expression without changes in the estradiol levels in the prostate of aging rats","volume":"10","author":"Morais-Santos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2016.11.016_bib66","doi-asserted-by":"crossref","first-page":"20090","DOI":"10.1073\/pnas.1117772108","article-title":"Estrogen receptor beta and 17beta-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer","volume":"108","author":"Muthusamy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mce.2016.11.016_bib67","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6602156","article-title":"Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer","volume":"91","author":"Myers","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2001551","article-title":"Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5","volume":"4","author":"Nakajima","year":"2011","journal-title":"Sci. Signal"},{"key":"10.1016\/j.mce.2016.11.016_bib69","doi-asserted-by":"crossref","first-page":"T219","DOI":"10.1530\/ERC-13-0508","article-title":"Estrogen receptor beta in prostate cancer: friend or foe?","volume":"21","author":"Nelson","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.steroids.2007.08.001","article-title":"5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats","volume":"72","author":"Oliveira","year":"2007","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2016.11.016_bib71","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0959-8049(01)00383-5","article-title":"Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers","volume":"38","author":"Omoto","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2010.06.003","article-title":"Estrogen receptor profiles in human peripheral blood lymphocytes","volume":"132","author":"Pierdominici","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.mce.2016.11.016_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/1471-2407-14-749","article-title":"ERbeta1: characterization, prognosis, and evaluation of treatment strategies in ERalpha-positive and -negative breast cancer","volume":"14","author":"Reese","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib74","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3109\/09513590.2011.588743","article-title":"Red clover and soy isoflavones\u2013an in\u00a0vitro safety assessment","volume":"27","author":"Reiter","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib75","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1096\/fj.07-9526com","article-title":"Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling","volume":"22","author":"Ricke","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2016.11.016_bib76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1677\/JME-07-0053","article-title":"Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signaling","volume":"39","author":"Risbridger","year":"2007","journal-title":"J.\u00a0Mol. Endocrinol."},{"issue":"R21","key":"10.1016\/j.mce.2016.11.016_bib77","article-title":"Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines","volume":"16","author":"Rizza","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib78","first-page":"2537","article-title":"Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors","volume":"61","author":"Roger","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.11.016_bib79","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0140-6736(92)90927-U","article-title":"5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males","volume":"339","author":"Ross","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2016.11.016_bib80","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/jcp.22461","article-title":"Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor alpha and beta","volume":"226","author":"Rossi","year":"2011","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.mce.2016.11.016_bib81","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1158\/1535-7163.MCT-13-1066","article-title":"Preferential estrogen receptor beta ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy","volume":"13","author":"Ruddy","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mce.2016.11.016_bib82","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jnci\/djn150","article-title":"Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer","volume":"100","author":"Setlur","year":"2008","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.mce.2016.11.016_bib83","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00000478-200312000-00002","article-title":"Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia","volume":"27","author":"Shaaban","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.mce.2016.11.016_bib84","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1098-2744(200010)29:2<92::AID-MC6>3.0.CO;2-Q","article-title":"Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells","volume":"29","author":"Shen","year":"2000","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.mce.2016.11.016_bib85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/path.1077","article-title":"Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue","volume":"197","author":"Skliris","year":"2002","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.mce.2016.11.016_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/hmbci-2013-0042","article-title":"Estrogen receptor beta: putting a positive into triple negative breast cancer?","volume":"16","author":"Smart","year":"2013","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.mce.2016.11.016_bib87","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/1535-7163.MCT-07-0197","article-title":"The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment","volume":"6","author":"Stettner","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mce.2016.11.016_bib88","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1349-7006.2008.00988.x","article-title":"Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma","volume":"99","author":"Suzuki","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.mce.2016.11.016_bib89","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1464-410X.2007.06924.x","article-title":"Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells","volume":"100","author":"Thelen","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.mce.2016.11.016_bib90","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/carcin\/bgi092","article-title":"Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer","volume":"26","author":"Thelen","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mce.2016.11.016_bib91","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1440-1827.2006.01983.x","article-title":"Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2\/neu overexpression","volume":"56","author":"Umekita","year":"2006","journal-title":"Pathol. Int."},{"key":"10.1016\/j.mce.2016.11.016_bib92","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2013new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mce.2016.11.016_bib93","doi-asserted-by":"crossref","first-page":"22059","DOI":"10.1074\/jbc.M110.114116","article-title":"Estrogen receptor beta binds to and regulates three distinct classes of target genes","volume":"285","author":"Vivar","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2016.11.016_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-006-9229-5","article-title":"Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions","volume":"100","author":"Weitsman","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2016.11.016_bib95","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3892\/ijo.2012.1689","article-title":"Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells","volume":"42","author":"Weng","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.mce.2016.11.016_bib96","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-014-3050-3","article-title":"ERbeta splice variant expression in four large cohorts of human breast cancer patient tumors","volume":"146","author":"Wimberly","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2016.11.016_bib97","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jcb.23443","article-title":"Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody","volume":"113","author":"Wu","year":"2012","journal-title":"J.\u00a0Cell Biochem."},{"key":"10.1016\/j.mce.2016.11.016_bib98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0960-0760(02)00259-5","article-title":"Phytoestrogens for hormone replacement therapy?","volume":"83","author":"Wuttke","year":"2002","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2016.11.016_bib99","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/me.2011-1101","article-title":"Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer","volume":"26","author":"Yang","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2016.11.016_bib100","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/pros.23017","article-title":"Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells","volume":"75","author":"Yang","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.mce.2016.11.016_bib101","doi-asserted-by":"crossref","first-page":"e56667","DOI":"10.1371\/journal.pone.0056667","article-title":"Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-beta activation","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2016.11.016_bib102","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/ERC-12-0402","article-title":"Estrogen receptor beta expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration-resistant disease","volume":"20","author":"Zellweger","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.11.016_bib103","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.011056","article-title":"Estrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activity","volume":"11","author":"Zhou","year":"2012","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.mce.2016.11.016_bib104","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0002-9440(10)63760-1","article-title":"Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis","volume":"164","author":"Zhu","year":"2004","journal-title":"Am. J. Pathol."}],"updated-by":[{"DOI":"10.1016\/j.mce.2017.01.048","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,3,5]],"date-time":"2017-03-05T00:00:00Z","timestamp":1488672000000}}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716304853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716304853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:43:44Z","timestamp":1783637024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720716304853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":104,"alternative-id":["S0303720716304853"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2016.11.016","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2016.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}